178 related articles for article (PubMed ID: 20307666)
1. Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs.
Kawamoto K; Pahuja A; Hering BJ; Bansal-Pakala P
Transpl Immunol; 2010 May; 23(1-2):28-33. PubMed ID: 20307666
[TBL] [Abstract][Full Text] [Related]
2. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
Sung JL; Lin JT; Gorham JD
Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in non-human primates.
Kim JS; Lee JI; Shin JY; Kim SY; Shin JS; Lim JH; Cho HS; Yoon IH; Kim KH; Kim SJ; Park CG
Transplantation; 2009 Dec; 88(12):1349-59. PubMed ID: 20029331
[TBL] [Abstract][Full Text] [Related]
6. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
[TBL] [Abstract][Full Text] [Related]
7. Naive human T-cells become non-responsive towards anti-TNFalpha (infliximab) treatment in vitro if co-stimulated through CD28.
Gunnlaugsdottir B; Skaftadottir I; Ludviksson BR
Scand J Immunol; 2008 Dec; 68(6):624-34. PubMed ID: 19000096
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: TGF-beta1 and IL-15 Induce FOXP3+ gammadelta regulatory T cells in the presence of antigen stimulation.
Casetti R; Agrati C; Wallace M; Sacchi A; Martini F; Martino A; Rinaldi A; Malkovsky M
J Immunol; 2009 Sep; 183(6):3574-7. PubMed ID: 19710458
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
10. The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent.
Gunnlaugsdottir B; Maggadottir SM; Skaftadottir I; Ludviksson BR
Scand J Immunol; 2013 Feb; 77(2):125-34. PubMed ID: 23126599
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
13. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
[TBL] [Abstract][Full Text] [Related]
15. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
Liu Y; Amarnath S; Chen W
Transplantation; 2006 Oct; 82(7):953-64. PubMed ID: 17038912
[TBL] [Abstract][Full Text] [Related]
16. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells.
Horie S; Sugita S; Futagami Y; Yamada Y; Mochizuki M
Clin Immunol; 2010 Jul; 136(1):83-95. PubMed ID: 20350837
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.
Karagiannidis C; Akdis M; Holopainen P; Woolley NJ; Hense G; Rückert B; Mantel PY; Menz G; Akdis CA; Blaser K; Schmidt-Weber CB
J Allergy Clin Immunol; 2004 Dec; 114(6):1425-33. PubMed ID: 15577848
[TBL] [Abstract][Full Text] [Related]
19. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.
Mantel PY; Kuipers H; Boyman O; Rhyner C; Ouaked N; Rückert B; Karagiannidis C; Lambrecht BN; Hendriks RW; Crameri R; Akdis CA; Blaser K; Schmidt-Weber CB
PLoS Biol; 2007 Dec; 5(12):e329. PubMed ID: 18162042
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive Foxp3+ regulatory cells.
Moreira-Teixeira L; Resende M; Devergne O; Herbeuval JP; Hermine O; Schneider E; Dy M; Cordeiro-da-Silva A; Leite-de-Moraes MC
J Immunol; 2012 Jan; 188(2):624-31. PubMed ID: 22156591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]